Shandong LINUO Pharmaceutical Packaging Co., Ltd. (301188.SZ) is a vertically integrated pharmaceutical glass manufacturer serving 10,000+ clients in 100+ countries since 1995.
Scroll Down
With 30+ years of expertise, LINUO Pharmaceutical Packaging is a listed global leader providing safe packaging for pharmaceuticals, medical aesthetics, and cosmetics. Serving 10,000+ clients across 100+ countries, we are trusted by 1 in 3 pharmaceutical companies worldwide.
Unmatched Scale & Supply Chain SecurityOperating a 900,000 m² Smart Factory with 500+ machines, we deliver 9.6B+ units annually. Our fully integrated supply chain — from producing 13K+ tons of glass tubing to finished tubular and molded vials — guarantees total material security and resilient delivery.
Quality, Compliance & Smart ManufacturingWe hold FDA DMF, EU CEP, and ISO 15378 certifications. Our CNAS-accredited lab ensures full compliance with ChP, USP, EP, and JP standards. Leveraging 100% AI inspection and patented “Zero Glass Debris” tech, we provide near-zero defect precision powered by Digital Twin technology and smart robotics.
Global Innovation & CustomizationWith R&D centers in Germany and Japan and production bases across the Middle East, Southeast Asia, and South America, we offer localized service globally. We specialize in PFS & RTU systems, supported by 130+ patents and a $4.2M annual R&D investment. Our 4-step process (Consult → Prototype → Validate → Mass Produce) delivers bespoke solutions in form, printing, and sterilization.
Industry AuthorityAs the host of China’s only Pharmaceutical Glass Training Base, LINUO integrates ESG principles with world-class manufacturing to lead the future of pharmaceutical glass packaging.
Independent Patents
Standards Contributor
Annual R&D Investment
Annual Sales
LINUO's 30-year history reflects a consistent trajectory from domestic pharmaceutical packaging manufacturer to global supplier of compliant, high-precision primary glass packaging.
To be a reliable pharmaceutical packaging company for global clients
Maximize the benefits for customers, society, employees and stockholders
Productism, Longtermism, Altruism
Behind LINUO's manufacturing excellence is a team of over 2,000 dedicated professionals — engineers, quality specialists, regulatory experts, and logistics coordinators — united by a shared commitment to pharmaceutical packaging precision.
LINUO maintains a substantial dedicated R&D budget, supported by a team of 49 R&D engineers. The company holds 130+ patents and has contributed to the development of 20+ national and industry standards for pharmaceutical glass packaging.
Our R&D network spans four continents. In addition to primary R&D facilities in Jinan, LINUO operates dedicated research centers in Germany and Japan, and maintains collaborative research relationships with GR Shanghai and GS Lab (Czech Republic).
Qilu University of Technology · Shandong University · Shanghai University · Shaanxi University of Science and Technology
Multiple regulatory registrations, including FDA DMF and Health Canada MF, support customer submissions across major pharmaceutical packaging product lines.
From in-house borosilicate glass tubing (13,000+ tons/year) to finished packaging — one source, zero inter-supplier variability.
Proprietary "Zero Glass Debris" technology and 12-camera AI systems deliver near-zero defect rates at full production speed.
Every order ships with FDA DMF reference letters, ISO certificates, CNAS test reports, EU CEP, and batch CoA — audit-ready from day one.
Digital Twin, MES full-process traceability, and KUKA robotics ensure every batch is traceable from raw materials to finished product.
Host of China's only Pharmaceutical Glass Training Base. Contributor to 20+ national standards. Technical leadership you can rely on.
As a publicly listed company, LINUO’s financial performance, quality management systems, and corporate governance are subject to regulatory oversight and public disclosure requirements — providing pharmaceutical buyers and supply chain partners with institutional accountability and transparency.
301188.SZ
Shenzhen Stock Exchange (SZSE), ChiNext BoardListing
11 November 2021
Serving 10,000+ clients across 100+ countries
with strong export coverage in Europe, Americas, Middle East, Southeast Asia and Africa.
Saudi Arabia
India
Pakistan
Indonesia
Thailand
Turkey
Australia
Egypt
Algeria
Morocco
Belarus
Argentina
Chile
Paraguay
Japan
South Korea
Mongolia
Canada
Mexico
Current project status and supply boundaries for Brazil and Egypt, based on internal project reporting.
Status verified: 15 September 2026Supply status Project-stage supply confirmation for qualification and customer review.
Boundary China factory supply of pharmaceutical glass packaging, subject to approved specifications and project qualification.
Sample and import path Request samples and the applicable import documentation through LINUO sales support.
Supply status Current offering: RTU (ready-to-use) pharmaceutical packaging for the confirmed project scope.
Boundary RTU glass vials and cartridges, plus heat-resistant glassware project items where specified; final SKU, pack format and release status require project confirmation.
Sample and import path Samples are arranged case by case; import route, consignee requirements and controlled documents are confirmed before shipment.
We will reply to you within 24 hours. If for urgent case, please add WhatsApp/WeChat: +8615953131507, Or call +8618615646416 directly.
*We respect your confidentiality and all information are protected.
We will only use your information to respond to your inquiry and will never send unsolicited emails or promotional messages.
